EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Oral decitabine–cedazuridine in acute myeloid leukaemia

Ian M Bouligny, Courtney D DiNardo iD

British Journal of Haematology · 2024-11 · 205 (5) · 1674-1676

DOI: 10.1111/bjh.19769 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Haematology, online erschienen am 23.09.2024. Verfasst von Ian M Bouligny und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Decitabine, Uridine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In a randomized crossover study involving 89 patients with acute myeloid leukaemia ineligible for intensive chemotherapy, Geissler et al. compared intravenous decitabine and oral decitabine–cedazuridine. The pharmacokinetics and pharmacodynamics of the two formulations were similar. The clinical efficacy of oral decitabine–cedazuridine was consistent with historical data of intravenous decitabine. Commentary on: Geissler et al. Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study. Br J Haematol 2024; 205: 1734‐1745 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteDecitabineUridineHumansAdministration, OralAntineoplastic Combined Chemotherapy ProtocolsCross-Over StudiesAzacitidineMaleFemale

Stichwörter der Autor:innen

acute myeloid leukemiadecitabinedecitabine‐cedazuridinepharmacokinetics

Substanzen

DecitabinecedazuridineUridineAzacitidine

Autor:innen und Institutionen

  • Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Courtney D DiNardo

Zitieren

APA

Bouligny, I. M., & DiNardo, C. D. (2024). Oral decitabine–cedazuridine in acute myeloid leukaemia. British Journal of Haematology, 205(5), 1674-1676. https://doi.org/10.1111/bjh.19769

Vancouver

Bouligny IM, DiNardo CD. Oral decitabine–cedazuridine in acute myeloid leukaemia. British Journal of Haematology. 2024;205(5):1674-1676. doi:10.1111/bjh.19769

BibTeX
@article{Bouligny2024,
  author = {Bouligny, Ian M and DiNardo, Courtney D},
  title = {Oral decitabine–cedazuridine in acute myeloid leukaemia},
  journal = {British Journal of Haematology},
  year = {2024},
  volume = {205},
  number = {5},
  pages = {1674--1676},
  doi = {10.1111/bjh.19769}
}
Kostenlos starten →